Contact us   |  

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Subnetwork: Myeloid malignancies

Disease group/s: Acute myeloid leukemia (AML)

Scope and Purpose: 2. Diagnosis

Patients' involvement?: No

Rigour of development: B - Consensus based

Link: https://www.ncbi.nlm.nih.gov/pubmed/29330221